StockGlow

Avicanna Inc. (AVCN.TO)

Develops cannabis-based medicines and pharmaceutical products for pain, seizures, and other conditions.

0.12-0.08%Healthcare
Compare AVCN.TO with
StockGlow Score
8
Bearish
BearishBullish
1 year ago-57.1%

The outlook

AVCN.TO is trading near its 52-week lows at $0.12, well below both its 50- and 200-day moving averages. The stock sits in the lower portion of its yearly range, reflecting sustained weakness over recent months. Current analyst coverage appears limited, and the overall market sentiment leans heavily bearish.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range12% of the way from its 52-week low to high
Market cap
$15.1M
52-wk high
0.30
52-wk low
0.10
50-day avg
0.13
200-day avg
0.18
Trailing P/E
—

Similar stocks

LABS.TOMediPharm Labs Corp.$0.08-6.25%PCLO.VPharmaCielo Ltd.$0.06-7.69%CRDL.TOCardiol Therapeutics Inc.$1.70+3.66%CWEB.TOCharlotte's Web Holdings, Inc.$0.33-4.35%OILS.CNNextleaf Solutions Ltd.$0.04-11.11%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy